Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2300224	注射用全氟丙烷人血白蛋白微球	Perfluoropropane-albumin	Lyophilized	Biological Products	Supplementary Application	2023-12-01		Xiamen Fuman Pharmaceutical Industry Co Ltd			view
CXSS2300049	注射用全氟丙烷人血白蛋白微球	Perfluoropropane-albumin	Lyophilized	Biological Products(2.2)	New Drug Application	2023-07-07		Xiamen Fuman Pharmaceutical Industry Co Ltd			view
CYSB2300058	注射用全氟丙烷人血白蛋白微球	Perfluoropropane-albumin	Lyophilized	Biological Products	Supplementary Application	2023-03-08		Xiamen Fuman Pharmaceutical Industry Co Ltd			view
CXSL2101431	注射用全氟丙烷人血白蛋白微球	Perfluoropropane-albumin	Lyophilized	Biological Products(2.2)	New Drug Application	2021-11-22		Xiamen Fuman Pharmaceutical Industry Co Ltd			view
CXSL2101390	注射用全氟丙烷人血白蛋白微球	Perfluoropropane-albumin	Lyophilized	Biological Products(2.2)	New Drug Application	2021-10-27		Xiamen Fuman Pharmaceutical Industry Co Ltd			view
CYSB2000358	注射用全氟丙烷人血白蛋白微球	Perfluoropropane-albumin	Lyophilized	Biological Products	Supplementary Application	2020-12-18	厦门力卓药业有限公司	Xiamen Fuman Pharmaceutical Industry Co Ltd	In Review	2021-06-15	view